Document:

<TABLE>
<CAPTION>
                             SCHEDULE OF PURCHASERS

                         PURCHASER                    WARRANTS PURCHASED
        --------------------------------------------  ------------------
<S>                                                   <C>
        Special Situations Fund III QP, L.P.                     500,000
        Special Situations Technology Fund,                       47,300
        Special Situations Technology Fund II, L.P.               252700
        Special Situations Private Equity Fund, L.P.             200,000
                                                      ------------------
            Total                                              1,000,000
                                                      ==================
</TABLE>

<PAGE>
NEITHER  THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE
NOR  THE  SECURITIES  INTO  WHICH  THESE  SECURITIES  ARE  EXERCISABLE HAVE BEEN
REGISTERED  UNDER  THE  SECURITIES  ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES  LAWS.  THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR  ASSIGNED  (I)  IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR
THE  SECURITIES  UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION
OF  COUNSEL,  IN  A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER  SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID
ACT.  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH  A  BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY  THE  SECURITIES.

                         CONCURRENT COMPUTER CORPORATION

                        WARRANT TO PURCHASE COMMON STOCK

Warrant  No.:
              -----------
Number  of  Shares  of  Common  Stock:
Date  of  Issuance:  May  18,  2007  ("ISSUANCE  DATE")

          Concurrent  Computer  Corporation,  a  Delaware  corporation  (the
"COMPANY"),  hereby  certifies  that,  for  good and valuable consideration, the
receipt  and  sufficiency of which are hereby acknowledged, [                 ],
the  registered  holder  hereof  or  its  permitted  assigns  (the "HOLDER"), is
entitled, subject to the terms set forth below, to purchase from the Company, at
the  Exercise  Price  (as  defined below) then in effect, upon surrender of this
Warrant  to  Purchase  Common  Stock  (including any Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, the "WARRANT"), at any
time  or times on or after the Issuance Date, but not after 11:59 p.m., New York
Time,  on the Expiration Date (as defined below) fully paid nonassessable shares
of  Common  Stock  (as defined below) (the "WARRANT SHARES") free from all liens
and  charges  with respect to the issuance thereof.  Except as otherwise defined
herein,  capitalized  terms in this Warrant shall have the meanings set forth in
Section  15.  This  Warrant is one of the Warrants (as defined in the Securities
Purchase Agreement) to purchase Common Stock (the "SPA WARRANTS" issued pursuant
to  Section 1 of that certain Securities Purchase Agreement, dated as of May 15,
2007 (the "SUBSCRIPTION DATE"), by and among the Company and the purchasers (the
"PURCHASERS")  referred  to  therein  (the  "SECURITIES  PURCHASE  AGREEMENT").

<PAGE>
          1.     EXERCISE  OF  WARRANT.
                 ---------------------

               (a)     Mechanics  of  Exercise.  Subject  to  the  terms  and
                       -----------------------
conditions  hereof, this Warrant may be exercised by the Holder on any day on or
after the Issuance Date, in whole or in part by delivery of a written notice, in
the  form  attached hereto as Exhibit B (the "EXERCISE NOTICE"), of the Holder's
                              ---------
election  to  exercise  this  Warrant  and (ii) (A) payment to the Company of an
amount  equal  to  the  applicable  Exercise  Price  multiplied by the number of
Warrant  Shares  as  to  which  this  Warrant is being exercised (the "AGGREGATE
EXERCISE  PRICE") in cash or wire transfer of immediately available funds or (B)
by  notifying  the  Company  that  this Warrant is being exercised pursuant to a
Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required
to  deliver  the  original  Warrant  in  order  to effect an exercise hereunder.
Execution  and  delivery of the Exercise Notice with respect to less than all of
the  Warrant  Shares  shall have the same effect as cancellation of the original
Warrant  and  issuance  of  a  new  Warrant evidencing the right to purchase the
remaining  number  of  Warrant Shares. On or before the first (1st) Business Day
following the date on which the Company has received each of the Exercise Notice
and  the  Aggregate  Exercise  Price  (or  notice  of  a Cashless Exercise) (the
"EXERCISE  DELIVERY  DOCUMENTS"),  the  Company  shall  transmit by facsimile an
acknowledgment  of confirmation of receipt of the Exercise Delivery Documents to
the Holder and the Company's transfer agent (the "TRANSFER AGENT"). On or before
the  third  (3rd)  Business  Day  following  the  date  on which the Company has
received all of the Exercise Delivery Documents (the "SHARE DELIVERY DATE"), the
Company  shall  (X)  provided  that  the  Transfer Agent is participating in The
Depository  Trust  Company  ("DTC")  Fast Automated Securities Transfer Program,
upon the request of the Holder, credit such aggregate number of shares of Common
Stock  to which the Holder is entitled pursuant to such exercise to the Holder's
or  its designee's balance account with DTC through its Deposit Withdrawal Agent
Commission  system, or (Y) if the Transfer Agent is not participating in the DTC
Fast  Automated  Securities  Transfer  Program,  issue and dispatch by overnight
courier  to  the  address  as  specified  in the Exercise Notice, a certificate,
registered  in  the  Company's  share  register in the name of the Holder or its
designee,  for  the  number  of  shares  of  Common Stock to which the Holder is
entitled  pursuant  to such exercise. If this Warrant is submitted in connection
with any exercise pursuant to this Section 1(a) and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of
Warrant  Shares  being acquired upon an exercise, then the Company shall as soon
as practicable and in no event later than three Business Days after any exercise
and  at  its  own expense, issue a new Warrant (in accordance with Section 7(d))
representing  the  right  to  purchase  the number of Warrant Shares purchasable
immediately  prior  to  such  exercise  under  this  Warrant, less the number of
Warrant  Shares  with  respect to which this Warrant is exercised. No fractional
shares  of  Common Stock are to be issued upon the exercise of this Warrant, but
rather  the number of shares of Common Stock to be issued shall be rounded up to
the  nearest  whole number. The Company shall pay any and all taxes which may be
payable  with  respect  to  the  issuance  and  delivery  of Warrant Shares upon
exercise  of  this  Warrant.

               (b)     Exercise  Price.  For purposes of this Warrant, "EXERCISE
                       ---------------
PRICE"  means  $1.62,  subject  to  adjustment  as  provided  herein.

               (c)     Company's  Failure  to Timely Deliver Securities.  If the
                       ------------------------------------------------
Company shall fail for any reason or for no reason to issue to the Holder within
three  (3)  Trading  Days  of  receipt  of  the  Exercise  Delivery Documents, a
certificate  for  the  number  of  shares of Common Stock to which the Holder is
entitled  and  register  such  shares  of  Common  Stock  on the Company's share
register  or  to

                                        2
<PAGE>
credit the Holder's balance account with DTC for such number of shares of Common
Stock  to  which  the  Holder  is  entitled  upon  the Holder's exercise of this
Warrant,  then,  in  addition to all other remedies available to the Holder, the
Company shall pay in cash to the Holder on each day after such third Trading Day
that  the  issuance  of  such  shares  of Common Stock is not timely effected an
amount  equal  to  0.5% of the product of (A) the sum of the number of shares of
Common  Stock not issued to the Holder on a timely basis and to which the Holder
is  entitled and (B) the Closing Sale Price of the shares of Common Stock on the
Trading Day immediately preceding the last possible date which the Company could
have  issued such shares of Common Stock to the Holder without violating Section
1(a).  In  addition to the foregoing, if within three (3) Trading Days after the
Company's  receipt  of the facsimile copy of a Exercise Notice the Company shall
fail  to  issue and deliver a certificate to the Holder and register such shares
of  Common  Stock on the Company's share register or credit the Holder's balance
account with DTC for the number of shares of Common Stock to which the Holder is
entitled  upon  such  holder's  exercise  hereunder  or  if the Company fails to
deliver  to  the  Holder  the  certificate  or  certificates  representing  the
applicable  Warrant  Shares  (or credit the Holder's balance account at DTC with
the  applicable  Warrant  Shares)  within  three  (3)  Trading  Days  after  its
obligation  to do so under clause (ii) below and if on or after such Trading Day
the  Holder  purchases  (in  an  open market transaction or otherwise) shares of
Common  Stock  to  deliver  in satisfaction of a sale by the Holder of shares of
Common  Stock  issuable upon such exercise that the Holder anticipated receiving
from the Company (a "BUY-IN"), then the Company shall, within three Trading Days
after  the  Holder's request and in the Holder's discretion, either (i) pay cash
to the Holder in an amount equal to the Holder's total purchase price (including
brokerage  commissions, if any) for the shares of Common Stock so purchased (the
"BUY-IN  PRICE"),  at  which  point  the  Company's  obligation  to deliver such
certificate  (and  to issue such shares of Common Stock) or credit such Holder's
balance  account with DTC shall terminate, or (ii) promptly honor its obligation
to  deliver to the Holder a certificate or certificates representing such shares
of Common Stock or credit such Holder's balance account with DTC and pay cash to
the  Holder  in  an amount equal to the excess (if any) of the Buy-In Price over
the product of (A) such number of shares of Common Stock, times (B) the proceeds
per  share  received  by such Holder as a result of the sale to which the Buy-In
relates.

               (d)     Cashless  Exercise.  Notwithstanding  anything  contained
                       ------------------
herein  to  the  contrary,  if  a  Registration  Statement  (as  defined  in the
Securities  Purchase Agreement) covering the Warrant Shares that are the subject
of  the  Exercise Notice (the "UNAVAILABLE WARRANT SHARES") is not available for
the  resale  of  such  Unavailable  Warrant  Shares, the Holder may, in its sole
discretion, exercise this Warrant in whole or in part and, in lieu of making the
cash payment otherwise contemplated to be made to the Company upon such exercise
in  payment  of the Aggregate Exercise Price, elect instead to receive upon such
exercise  the "Net Number" of shares of Common Stock determined according to the
following  formula  (a  "CASHLESS  EXERCISE"):

               Net  Number  =  (A  x  B)  -  (A  x  C)
                               -----------------------

                                          B

                                        3
<PAGE>
               For  purposes  of  the  foregoing  formula:

          A=  the  total  number  of  shares  with respect to which this Warrant
          is  then  being  exercised.

          B=  the  Weighted  Average  Price  of  the  shares of Common Stock (as
          reported  by  Bloomberg)  for  the  five  (5) consecutive Trading Days
          ending  on  the  date  immediately  preceding the date of the Exercise
          Notice.

          C=  the  Exercise  Price  then  in  effect  for the applicable Warrant
          Shares  at  the  time  of  such  exercise.

               (e)     Disputes.  In  the  case  of  a  dispute  as  to  the
                       --------
determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares,  the  Company  shall  promptly issue to the Holder the number of Warrant
Shares that are not disputed and resolve such dispute in accordance with Section
12.

               (f)     [Reserved]
                       ----------

               (g)     Insufficient  Authorized  Shares.  If  at  any time while
                       --------------------------------
this  Warrant  remains outstanding the Company does not have a sufficient number
of authorized and unreserved shares of Common Stock to satisfy its obligation to
reserve  for  issuance upon exercise of this Warrant at least a number of shares
of  Common  Stock equal to 100% (the "REQUIRED RESERVE AMOUNT") of the number of
shares  of  Common  Stock  as shall from time to time be necessary to effect the
exercise  of  all  of  this  Warrant  then  outstanding  (an  "AUTHORIZED  SHARE
FAILURE"),  then  the  Company  shall  immediately  take all action necessary to
increase the Company's authorized shares of Common Stock to an amount sufficient
to  allow  the  Company  to reserve the Required Reserve Amount for this Warrant
then outstanding.  Without limiting the generality of the foregoing sentence, as
soon  as  practicable  after  the  date of the occurrence of an Authorized Share
Failure,  but in no event later than one hundred and twenty (120) days after the
occurrence of such Authorized Share Failure, the Company shall hold a meeting of
its  stockholders  for  the  approval of an increase in the number of authorized
shares  of  Common  Stock.  In  connection  with such meeting, the Company shall
provide  each  stockholder  with  a proxy statement and shall use its reasonable
best  efforts  to  solicit  its  stockholders'  approval  of  such  increase  in
authorized  shares  of  Common  Stock  and  to  cause  its board of directors to
recommend  to  the  stockholders  that  they  approve  such  proposal.

          2.     ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES.   If
                 ---------------------------------------------------------
the  Company  at  any  time on or after the Subscription Date subdivides (by any
stock  split, stock dividend, recapitalization or otherwise) one or more classes
of  its  outstanding shares of Common Stock into a greater number of shares, the
Exercise  Price  in  effect  immediately  prior  to  such  subdivision  will  be
proportionately reduced and the number of Warrant Shares will be proportionately
increased.  If  the  Company  at  any  time  on  or  after the Subscription Date
combines  (by combination, reverse stock split or otherwise) one or more classes
of  its  outstanding shares of Common Stock into a smaller number of shares, the
Exercise  Price  in  effect  immediately  prior  to  such  combination  will  be
proportionately  increased  and  the  number  of  Warrant  Shares  will  be

                                        4
<PAGE>
proportionately  decreased.  Any  adjustment  under  this Section 2 shall become
effective  at  the  close of business on the date the subdivision or combination
becomes  effective.

          3.     RIGHTS  UPON DISTRIBUTION OF ASSETS.  In case the Company shall
                 -----------------------------------
fix  a  payment  date  for the making of a distribution to all holders of Common
Stock  of evidences of indebtedness or assets (other than cash dividends or cash
distributions  payable  out  of  consolidated  earnings  or  earned  surplus  or
dividends  or  distributions referred to in Section 2), the Exercise Price to be
in  effect  after  such  payment  date  shall  be  determined by multiplying the
Exercise  Price  in effect immediately prior to such payment date by a fraction,
the  numerator  of  which  shall  be  the total number of shares of Common Stock
outstanding  multiplied  by the Weighted Average Price per share of Common Stock
immediately  prior  to  such  payment  date,  less  the  fair  market  value (as
determined  by the Company's Board of Directors in good faith) of said assets or
evidences  of indebtedness so distributed, and the denominator of which shall be
the  total  number  of  shares  of  Common  Stock outstanding multiplied by such
Weighted  Average  Price  per  share  of  Common Stock immediately prior to such
payment  date.  Such  adjustment  shall  be  made  successively  whenever such a
payment  date  is  fixed.

          4.     PURCHASE  RIGHTS;  FUNDAMENTAL  TRANSACTIONS.
                 --------------------------------------------

               (a)     Purchase Rights.  In addition to any adjustments pursuant
                       ---------------
to  Section  2  above,  if  at  any time the Company grants, issues or sells any
Options,  Convertible  Securities  or  rights  to  purchase  stock,  warrants,
securities  or  other  property  pro  rata to the record holders of any class of
shares of Common Stock (the "PURCHASE RIGHTS"), then the Holder will be entitled
to  acquire,  upon  the  terms applicable to such Purchase Rights, the aggregate
Purchase  Rights which the Holder could have acquired if the Holder had held the
number  of  shares  of  Common  Stock  acquirable upon complete exercise of this
Warrant  (without  regard  to  any  limitations on the exercise of this Warrant)
immediately  before  the date on which a record is taken for the grant, issuance
or  sale of such Purchase Rights, or, if no such record is taken, the date as of
which  the record holders of shares of Common Stock are to be determined for the
grant,  issue  or  sale  of  such  Purchase  Rights.

               (b)     Fundamental  Transactions.  The  Company  shall not enter
                       -------------------------
into  or  be party to a Fundamental Transaction unless (i)  the Successor Entity
assumes  in writing all of the obligations of the Company under this Warrant and
the  other  Transaction  Documents  in  accordance  with  the provisions of this
Section  (4)(b)  prior  to such Fundamental Transaction, including agreements to
deliver  to  each holder of Warrants in exchange for such Warrants a security of
the  Successor Entity evidenced by a written instrument substantially similar in
form  and  substance to this Warrant, including, without limitation, an adjusted
exercise  price  equal  to the value for the shares of Common Stock reflected by
the  terms  of such Fundamental Transaction, and exercisable for a corresponding
number  of  shares  of  capital  stock  equivalent to the shares of Common Stock
acquirable  and  receivable upon exercise of this Warrant (without regard to any
limitations  on  the  exercise  of  this  Warrant)  prior  to  such  Fundamental
Transaction  and  (ii)  (I)  the  Successor  Entity  (or its Parent Entity) is a
publicly  traded  corporation  whose  common  stock  is  quoted on or listed for
trading  on an Eligible Market or (II) the Successor Entity is a private company
and  the  consideration  paid  in  such  Fundamental  Transaction is solely cash
consideration.  Upon  the  occurrence  of  any  Fundamental  Transaction,  the
Successor  Entity  shall  succeed  to,  and be substituted for (so that from and
after  the  date  of  such  Fundamental  Transaction,  the  provisions

                                        5
<PAGE>
of  this Warrant referring to the "Company" shall refer instead to the Successor
Entity),  and may exercise every right and power of the Company and shall assume
all of the obligations of the Company under this Warrant with the same effect as
if  such  Successor  Entity  had  been  named  as  the  Company  herein.  Upon
consummation  of the Fundamental Transaction, the Successor Entity shall deliver
to  the  Holder  confirmation  that  there shall be issued upon exercise of this
Warrant  at  any  time after the consummation of the Fundamental Transaction, in
lieu  of  the  shares  of the Common Stock (or other securities, cash, assets or
other  property  purchasable  upon  the  exercise  of  the Warrant prior to such
Fundamental  Transaction,  such shares of stock, securities, cash, assets or any
other  property whatsoever (including warrants or other purchase or subscription
rights)  which the Holder would have been entitled to receive upon the happening
of  such  Fundamental  Transaction  had  this Warrant been converted immediately
prior  to  such  Fundamental  Transaction,  as  adjusted  in accordance with the
provisions  of  this  Warrant.  In  addition  to and not in substitution for any
other rights hereunder, prior to the consummation of any Fundamental Transaction
pursuant  to  which  holders  of  shares of Common Stock are entitled to receive
securities  or  other assets with respect to or in exchange for shares of Common
Stock  (a  "CORPORATE  EVENT"),  the Company shall make appropriate provision to
insure  that  the  Holder  will  thereafter  have  the  right to receive upon an
exercise  of  this Warrant within ninety (90) days after the consummation of the
Fundamental  Transaction but prior to the Expiration Date, in lieu of the shares
of  the  Common  Stock  (or  other  securities,  cash, assets or other property)
purchasable  upon  the  exercise  of  the  Warrant  prior  to  such  Fundamental
Transaction,  such  shares  of  stock,  securities,  cash,  assets  or any other
property  whatsoever  (including  warrants  or  other  purchase  or subscription
rights)  which the Holder would have been entitled to receive upon the happening
of such Fundamental Transaction had the Warrant been exercised immediately prior
to  such  Fundamental  Transaction.  The  provisions of this Section shall apply
similarly  and  equally  to  successive  Fundamental  Transactions and Corporate
Events and shall be applied without regard to any limitations on the exercise of
this  Warrant.

          5.     NONCIRCUMVENTION.  The Company hereby covenants and agrees that
                 ----------------
the  Company  will not, by amendment of its Certificate of Incorporation, Bylaws
or through any reorganization, transfer of assets, consolidation, merger, scheme
of arrangement, dissolution, issue or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms
of  this  Warrant,  and  will  at  all  times  in  good  faith carry out all the
provisions of this Warrant and take all action as may be required to protect the
rights  of  the  Holder.  Without  limiting the generality of the foregoing, the
Company  (i)  shall  not  increase  the  par value of any shares of Common Stock
receivable  upon  the  exercise of this Warrant above the Exercise Price then in
effect  and, (ii) shall take all such actions as may be necessary or appropriate
in  order  that  the  Company  may  validly  and  legally  issue  fully paid and
nonassessable  shares  of  Common  Stock  upon  the  exercise  of  this Warrant.

          6.     WARRANT  HOLDER  NOT DEEMED A STOCKHOLDER.  Except as otherwise
                 -----------------------------------------
specifically  provided herein, the Holder, solely in such Person's capacity as a
holder of this Warrant, shall not be entitled to vote or receive dividends or be
deemed  the  holder  of  share capital of the Company for any purpose, nor shall
anything  contained  in  this  Warrant  be  construed to confer upon the Holder,
solely  in  such  Person's  capacity  as  the Holder of this Warrant, any of the
rights  of  a  stockholder of the Company or any right to vote, give or withhold
consent  to  any  corporate  action (whether any reorganization, issue of stock,
reclassification  of  stock,  consolidation,  merger,  conveyance or otherwise),
receive  notice  of  meetings,  receive  dividends  or

                                        6
<PAGE>
subscription  rights,  or  otherwise, prior to the issuance to the Holder of the
Warrant  Shares  which  such  Person  is  then  entitled to receive upon the due
exercise  of this Warrant.  In addition, nothing contained in this Warrant shall
be  construed  as  imposing  any  liabilities  on  the  Holder  to  purchase any
securities  (upon  exercise of this Warrant or otherwise) or as a stockholder of
the  Company,  whether  such  liabilities  are  asserted  by  the  Company or by
creditors  of  the  Company.  Notwithstanding  this Section 6, the Company shall
provide  the  Holder with copies of the same notices and other information given
to  the stockholders of the Company generally, contemporaneously with the giving
thereof  to  the  stockholders.

          7.     REISSUANCE  OF  WARRANTS.
                 ------------------------

               (a)     Transfer  of  Warrant.  If  this  Warrant  is  to  be
                       ---------------------
transferred,  the  Holder shall surrender this Warrant to the Company, whereupon
the  Company will forthwith issue and deliver upon the order of the Holder a new
Warrant (in accordance with Section 7(d)), registered as the Holder may request,
representing  the  right  to  purchase  the  number  of  Warrant  Shares  being
transferred  by  the Holder and, if less then the total number of Warrant Shares
then  underlying this Warrant is being transferred, a new Warrant (in accordance
with  Section  7(d)) to the Holder representing the right to purchase the number
of  Warrant  Shares  not  being  transferred.

               (b)     Lost,  Stolen  or Mutilated Warrant.  Upon receipt by the
                       -----------------------------------
Company  of  evidence reasonably satisfactory to the Company of the loss, theft,
destruction  or  mutilation  of this Warrant, and, in the case of loss, theft or
destruction,  of any indemnification undertaking by the Holder to the Company in
customary  form  and, in the case of mutilation, upon surrender and cancellation
of  this  Warrant,  the  Company  shall  execute and deliver to the Holder a new
Warrant (in accordance with Section 7(d)) representing the right to purchase the
Warrant  Shares  then  underlying  this  Warrant.

               (c)     Exchangeable  for  Multiple  Warrants.  This  Warrant  is
                       -------------------------------------
exchangeable, upon the surrender hereof by the Holder at the principal office of
the  Company,  for  a  new Warrant or Warrants (in accordance with Section 7(d))
representing in the aggregate the right to purchase the number of Warrant Shares
then underlying this Warrant, and each such new Warrant will represent the right
to  purchase  such portion of such Warrant Shares as is designated by the Holder
at  the  time  of  such  surrender;  provided,  however,  that  no  Warrants for
fractional  shares  of  Common  Stock  shall  be  given.

               (d)     Issuance  of  New  Warrants.  Whenever  the  Company  is
                       ---------------------------
required  to issue a new Warrant pursuant to the terms of this Warrant, such new
Warrant  (i)  shall be of like tenor with this Warrant, (ii) shall represent, as
indicated  on  the  face  of such new Warrant, the right to purchase the Warrant
Shares  then  underlying  this  Warrant  (or  in the case of a new Warrant being
issued  pursuant  to Section 7(a) or Section 7(c), the Warrant Shares designated
by  the  Holder  which,  when  added  to  the  number  of shares of Common Stock
underlying  the other new Warrants issued in connection with such issuance, does
not  exceed  the  number  of Warrant Shares then underlying this Warrant), (iii)
shall  have an issuance date, as indicated on the face of such new Warrant which
is  the  same  as  the  Issuance  Date,  and (iv) shall have the same rights and
conditions  as  this  Warrant.

          8.     NOTICES.  Whenever  notice  is  required to be given under this
                 -------
Warrant,  unless  otherwise  provided  herein,  such  notice  shall  be given in
accordance  with  Section  9  of  the

                                        7
<PAGE>
Securities Purchase Agreement.  The Company shall provide the Holder with prompt
written  notice  of  all  actions  taken  pursuant to this Warrant, including in
reasonable  detail  a  description  of  such  action  and  the reason therefore.
Without  limiting the generality of the foregoing, the Company will give written
notice  to the Holder (i) immediately upon any adjustment of the Exercise Price,
setting  forth  in  reasonable  detail,  and certifying, the calculation of such
adjustment  and  (ii)  at  least  ten  (10)  days prior to the date on which the
Company  closes  its books or takes a record (A) with respect to any dividend or
distribution  upon the shares of Common Stock or (B) with respect to any grants,
issuances  or sales of any Options, Convertible Securities or rights to purchase
stock,  warrants,  securities  or  other property to holders of shares of Common
Stock.

          9.     AMENDMENT AND WAIVER.  Except as otherwise provided herein, the
                 --------------------
provisions  of  this  Warrant may be amended and the Company may take any action
herein prohibited, or omit to perform any act herein required to be performed by
it,  only  if  the  Company  has  obtained  the  written consent of the Required
Holders; provided that no such action may increase the exercise price of any SPA
Warrant  or  decrease  the  number  of  shares or class of stock obtainable upon
exercise  of any SPA Warrant without the written consent of the Holder.  No such
amendment  shall  be effective to the extent that it applies to less than all of
the  holders  of  the  SPA  Warrants  then  outstanding.

          10.     GOVERNING  LAW  AND  FORUM.  This Warrant shall be governed by
                  --------------------------
and construed and enforced in accor-dance with, and all questions concerning the
construction,  validity, interpretation and performance of this Warrant shall be
governed  by,  the  internal  laws of the State of New York.  The parties hereto
agree to submit to the exclusive jurisdiction of the federal and state courts of
the  State of New York with respect to the interpretation of this Warrant or for
the  purposes  of  any  action  arising  out  of  or  related  to  this Warrant.

          11.     CONSTRUCTION;  HEADINGS.  This  Warrant  shall be deemed to be
                  -----------------------
jointly drafted by the Company and all the Purchasers and shall not be construed
against  any person as the drafter hereof.  The headings of this Warrant are for
convenience  of  reference  and  shall  not  form  part  of,  or  affect  the
interpretation  of,  this  Warrant.

          12.     DISPUTE  RESOLUTION.  In  the  case  of  a  dispute  as to the
                  -------------------
determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares,  the  Company  shall  submit  the  disputed determinations or arithmetic
calculations  via  facsimile  within  two  (2)  Business  Days of receipt of the
Exercise  Notice giving rise to such dispute, as the case may be, to the Holder.
If  the  Holder  and  the Company are unable to agree upon such determination or
calculation  of  the  Exercise Price or the Warrant Shares within three Business
Days of such disputed determination or arithmetic calculation being submitted to
the  Holder,  then  the  Company  shall, within two (2) Business Days submit via
facsimile  the  disputed  determination of the Exercise Price to an independent,
reputable  investment  bank  selected by the Company and approved by the Holder.
The  Company  shall  cause  at  its  expense  the investment bank to perform the
determinations  or  calculations  and  notify  the Company and the Holder of the
results  no  later  than  ten  (10)  Business Days from the time it receives the
disputed determinations or calculations.  Such investment bank's or accountant's
determination  or  calculation,  as  the  case may be, shall be binding upon all
parties  absent  demonstrable  error.

                                        8
<PAGE>
          13.     REMEDIES,  OTHER  OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF.
                  -------------------------------------------------------------
The remedies provided in this Warrant shall be cumulative and in addition to all
other remedies available under this Warrant and the other Transaction Documents,
at  law  or  in  equity (including a decree of specific performance and/or other
injunctive  relief),  and  nothing herein shall limit the right of the Holder to
pursue actual damages for any failure by the Company to comply with the terms of
this  Warrant.  The  Company acknowledges that a breach by it of its obligations
hereunder  will  cause irreparable harm to the Holder and that the remedy at law
for  any  such  breach may be inadequate.  The Company therefore agrees that, in
the  event  of  any such breach or threatened breach, the holder of this Warrant
shall be entitled, in addition to all other available remedies, to an injunction
restraining  any  breach,  without  the  necessity  of showing economic loss and
without  any  bond  or  other  security  being  required.

          14.     TRANSFER.     This  Warrant  may  be  offered  for sale, sold,
                  --------
transferred  or  assigned  without  the  consent  of  the Company, except as may
otherwise be required by Section 6.3 of the Securities Purchase Agreement.  This
Warrant  is  a  "restricted  security"  as  such  term  is  defined  in Rule 144
promulgated  under  the  Securities  Act  and  must  be held indefinitely unless
transferred  pursuant  to  an exemption from registration or qualification under
applicable  state  and  federal  securities  laws.

          15.     CERTAIN  DEFINITIONS.  For  purposes  of  this  Warrant,  the
                  --------------------
following  terms  shall  have  the  following  meanings:

               (a)     "BLOOMBERG"  means  Bloomberg  Financial  Markets.

               (b)     "BUSINESS  DAY" means any day other than Saturday, Sunday
or other day on which commercial banks in The City of New York are authorized or
required  by  law  to  remain  closed.

               (c)     "CLOSING  BID  PRICE" and "CLOSING SALE PRICE" means, for
any  security  as of any date, the last closing bid price and last closing trade
price,  respectively,  for such security on the Principal Market, as reported by
Bloomberg,  or,  if  the Principal Market begins to operate on an extended hours
basis  and  does not designate the closing bid price or the closing trade price,
as  the  case  may  be,  then  the  last  bid  price  or  the  last trade price,
respectively, of such security prior to 4:00 p.m., New York Time, as reported by
Bloomberg,  or, if the Principal Market is not the principal securities exchange
or  trading  market  for such security, the last closing bid price or last trade
price,  respectively,  of  such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg,
or  if  the  foregoing  do  not  apply, the last closing bid price or last trade
price,  respectively,  of  such  security  in the over-the-counter market on the
electronic  bulletin board for such security as reported by Bloomberg, or, if no
closing  bid  price  or  last  trade  price,  respectively, is reported for such
security  by  Bloomberg,  the  average  of  the  bid  prices, or the ask prices,
respectively,  of  any  market makers for such security as reported in the "pink
sheets"  by  Pink Sheets LLC (formerly the National Quotation Bureau, Inc.).  If
the  Closing  Bid  Price  or  the  Closing Sale Price cannot be calculated for a
security  on  a  particular  date on any of the foregoing bases, the Closing Bid
Price  or  the  Closing Sale Price, as the case may be, of such security on such
date  shall  be  the fair market value as mutually determined by the Company and
the  Holder.  If  the  Company  and the Holder are unable to agree upon the fair
market  value  of such security, then such dispute shall be resolved pursuant to
Section  12.  All  such  determinations  to  be

                                        9
<PAGE>
appropriately adjusted for any stock dividend, stock split, stock combination or
other  similar  transaction  during  the  applicable  calculation  period.

               (d)     "COMMON  STOCK"  means (i) the Company's shares of Common
Stock,  $0.01 par value, and (ii) any share capital into which such Common Stock
shall  have  been changed or any share capital resulting from a reclassification
of  such  Common  Stock.

               (e)     "CONVERTIBLE  SECURITIES"  means  any stock or securities
(other  than  Options) directly or indirectly convertible into or exercisable or
exchangeable  for  shares  of  Common  Stock.

               (f)     "ELIGIBLE  MARKET"  means  the  Principal  Market,  the
American  Stock  Exchange, The New York Stock Exchange, Inc., The NASDAQ Capital
Market  or  The  NASDAQ  Global  Select  Market.

               (g)     "EXPIRATION  DATE" means the date sixty (60) months after
the  Issuance Date or, if such date falls on a day other than a Trading Day, the
next  Trading  Day.

               (h)     "FUNDAMENTAL  TRANSACTION"  means that the Company shall,
directly  or indirectly, in one or more related transactions, (i) consolidate or
merge  with  or  into  (whether or not the Company is the surviving corporation)
another  Person,  or (ii) sell, assign, transfer, convey or otherwise dispose of
all  or  substantially all of the properties or assets of the Company to another
Person,  or  (iii)  allow  another Person to make a purchase, tender or exchange
offer  that  is  accepted  by  the  holders  of  more than the 50% of either the
outstanding  shares  of  Common  Stock (not including any shares of Common Stock
held  by  the  Person or Persons making or party to, or associated or affiliated
with  the  Persons making or party to, such purchase, tender or exchange offer),
or  (iv)  consummate  a  stock  purchase agreement or other business combination
(including,  without limitation, a reorganization, recapitalization or scheme of
arrangement)  with  another  Person whereby such other Person acquires more than
the  50%  of the outstanding shares of Common Stock (not including any shares of
Common  Stock  held  by the other Person or other Persons making or party to, or
associated  or  affiliated with the other Persons making or party to, such stock
purchase  agreement  or  other  business  combination),  or  (v)  reorganize,
recapitalize or reclassify its Common Stock, or (vi) any "person" or "group" (as
these  terms  are  used for purposes of Sections 13(d) and 14(d) of the Exchange
Act)  is  or shall become the "beneficial owner" (as defined in Rule 13d-3 under
the  Exchange  Act),  directly  or  indirectly, of 50% of the aggregate ordinary
voting  power  represented  by  issued  and  outstanding  Common  Stock.

               (i)     "OPTIONS"  means  any  rights,  warrants  or  options  to
subscribe  for  or  purchase  shares  of Common Stock or Convertible Securities.

               (j)     "PARENT  ENTITY"  of  a  Person  means  an  entity  that,
directly or indirectly, controls the applicable Person and whose common stock or
equivalent  equity  security  is  quoted or listed on an Eligible Market, or, if
there is more than one such Person or Parent Entity, the Person or Parent Entity
with  the largest public market capitalization as of the date of consummation of
the  Fundamental  Transaction.

                                       10
<PAGE>
               (k)     "PERSON"  means  an  individual,  a  limited  liability
company,  a  partnership,  a  joint  venture,  a  corporation,  a  trust,  an
unincorporated organization, any other entity and a government or any department
or  agency  thereof.

               (l)     "PRINCIPAL  MARKET"  means  The  NASDAQ  Global  Market.

               (m)     "REQUIRED  HOLDERS" means the holders of the SPA Warrants
representing  at  least  a majority of shares of Common Stock underlying the SPA
Warrants  then  outstanding.

               (n)     "SUCCESSOR ENTITY" means the Person (or, if so elected by
the  Required Holders, the Parent Entity) formed by, resulting from or surviving
any  Fundamental  Transaction  or  the  Person  with  which  such  Fundamental
Transaction  shall  have  been  entered  into.

               (o)     "TRADING  DAY" means any day on which the Common Stock is
traded on the Principal Market, or, if the Principal Market is not the principal
trading  market  for the Common Stock, then on the principal securities exchange
or  securities  market  on  which the Common Stock is then traded; provided that
"Trading  Day"  shall not include any day on which the Common Stock is scheduled
to  trade on such exchange or market for less than 4.5 hours or any day that the
Common  Stock is suspended from trading during the final hour of trading on such
exchange  or market (or if such exchange or market does not designate in advance
the  closing  time  of  trading on such exchange or market, then during the hour
ending  at  4:00  p.m.,  New  York  Time).

               (p)     "WEIGHTED  AVERAGE  PRICE"  means, for any security as of
any  date,  the  dollar  volume-weighted  average price for such security on the
Principal  Market  during the period beginning at 9:30 a.m., New York City time,
and  ending  at  4:00 p.m., New York City time, as reported by Bloomberg through
its  "Volume  at Price" function or, if the foregoing does not apply, the dollar
volume-weighted average price of such security in the over-the-counter market on
the  electronic  bulletin board for such security during the period beginning at
9:30  a.m.,  New York City time, and ending at 4:00 p.m., New York City time, as
reported  by  Bloomberg,  or,  if  no  dollar  volume-weighted  average price is
reported  for  such  security  by  Bloomberg  for such hours, the average of the
highest  closing bid price and the lowest closing ask price of any of the market
makers  for  such  security  as reported in the "pink sheets" by Pink Sheets LLC
(formerly  the  National Quotation Bureau, Inc.).  If the Weighted Average Price
cannot  be  calculated  for  such  security on such date on any of the foregoing
bases,  the  Weighted  Average  Price of such security on such date shall be the
fair  market  value  as  mutually  determined  by  the  Company and the Required
Holders.  If  the  Company and the Required Holders are unable to agree upon the
fair  market  value  of  the  such security, then such dispute shall be resolved
pursuant  to Section 12 with the term "Weighted Average Price" being substituted
for  the  term  "Exercise Price." All such determinations shall be appropriately
adjusted for any share dividend, share split or other similar transaction during
such  period.

                            [SIGNATURE PAGE FOLLOWS]

                                       11
<PAGE>
     IN  WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common
Stock  to  be  duly  executed  as  of  the  Issuance  Date  set  out  above.

                                        CONCURRENT COMPUTER CORPORATION

                                        By:
                                            ------------------------------------
                                                Name:
                                                Title:

<PAGE>
EXHIBIT  A

                                 EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS
                        WARRANT TO PURCHASE COMMON STOCK

                         CONCURRENT COMPUTER CORPORATION
     The  undersigned  holder  hereby  exercises  the  right  to  purchase
                  of the shares of Common Stock ("WARRANT SHARES") of Concurrent
-----------------
Computer  Corporation,  a Delaware corporation (the "COMPANY"), evidenced by the
attached  Warrant  to  Purchase Common Stock (the "WARRANT").  Capitalized terms
used  herein  and  not  otherwise defined shall have the respective meanings set
forth  in  the  Warrant.

     1.  Form  of  Exercise  Price.  The  Holder  intends  that  payment  of the
Exercise  Price  shall  be  made  as:

                           a  "Cash  Exercise" with respect to
          ------------        ----------------                 -----------------
                    Warrant  Shares;  and/or

                           a "Cashless Exercise" with respect to
          ------------       -------------------                 ---------------
                    Warrant  Shares.

     2.  Payment  of Exercise Price.  In the event that the holder has elected a
Cash  Exercise  with  respect  to some or all of the Warrant Shares to be issued
pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of
$                    to the Company in accordance with the terms of the Warrant.
 -------------------

     3.  Delivery  of  Warrant  Shares.  The Company shall deliver to the holder
            Warrant  Shares  in  accordance  with  the  terms  of  the  Warrant.
-----------

Date:                     ,
       ---------------  --   ------

-----------------------------------
   Name  of  Registered  Holder

By:
     ------------------------------
     Name:
     Title:

<PAGE>
                                 ACKNOWLEDGMENT

     The  Company  hereby  acknowledges  this Exercise Notice and hereby directs
American  Stock  Transfer & Trust Company to issue the above indicated number of
shares  of Common Stock in accordance with the Transfer Agent Instructions dated
May  18,  2007 from the Company and acknowledged and agreed to by American Stock
Transfer  &  Trust  Company.

                                        CONCURRENT COMPUTER CORPORATION

                                        By:
                                             -----------------------------------
                                                 Name:
                                                 Title:<TABLE>
<CAPTION>
                             SCHEDULE OF PURCHASERS

                         PURCHASER                  WARRANTS PURCHASED
         -----------------------------------------  ------------------
<S>                                                 <C>
         Fort Mason Master, LP                                 939,100
         Fort Mason Partners, LP                                60,900
         LB I Group Inc.                                       600,000
         Prism Partners I, L.P.                                 30,000
         Prism Partners II Offshore Fund                        22,000
         Prism Partners III Leveraged L.P.                      74,000
         Prism Partners IV Leveraged Offshore Fund              70,000
         Prism Partners Offshore Fund                            4,000
                                                    ------------------
             Total                                           1,800,000
                                                    ==================
</TABLE>

<PAGE>
NEITHER  THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE
NOR  THE  SECURITIES  INTO  WHICH  THESE  SECURITIES  ARE  EXERCISABLE HAVE BEEN
REGISTERED  UNDER  THE  SECURITIES  ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES  LAWS.  THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR  ASSIGNED  (I)  IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR
THE  SECURITIES  UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION
OF  COUNSEL,  IN  A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER  SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID
ACT.  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH  A  BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY  THE  SECURITIES.

                         CONCURRENT COMPUTER CORPORATION

                        WARRANT TO PURCHASE COMMON STOCK

Warrant  No.:
              --------
Number  of  Shares  of  Common  Stock:
Date  of  Issuance:  May  18,  2007  ("ISSUANCE  DATE")

          Concurrent  Computer  Corporation,  a  Delaware  corporation  (the
"COMPANY"),  hereby  certifies  that,  for  good and valuable consideration, the
receipt  and  sufficiency of which are hereby acknowledged, [                 ],
the  registered  holder  hereof  or  its  permitted  assigns  (the "HOLDER"), is
entitled, subject to the terms set forth below, to purchase from the Company, at
the  Exercise  Price  (as  defined below) then in effect, upon surrender of this
Warrant  to  Purchase  Common  Stock  (including any Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, the "WARRANT"), at any
time  or times on or after the Issuance Date, but not after 11:59 p.m., New York
Time,  on the Expiration Date (as defined below) fully paid nonassessable shares
of  Common  Stock  (as defined below) (the "WARRANT SHARES") free from all liens
and  charges  with respect to the issuance thereof.  Except as otherwise defined
herein,  capitalized  terms in this Warrant shall have the meanings set forth in
Section  15.  This  Warrant is one of the Warrants (as defined in the Securities
Purchase Agreement) to purchase Common Stock (the "SPA WARRANTS" issued pursuant
to  Section 1 of that certain Securities Purchase Agreement, dated as of May 15,
2007 (the "SUBSCRIPTION DATE"), by and among the Company and the purchasers (the
"PURCHASERS")  referred  to  therein  (the  "SECURITIES  PURCHASE  AGREEMENT").

<PAGE>
          1.     EXERCISE  OF  WARRANT.
                 ---------------------

               (a)     Mechanics  of  Exercise.  Subject  to  the  terms  and
                       -----------------------
conditions  hereof  (including, without limitation, the limitations set forth in
Section  1(f)),  this  Warrant  may  be exercised by the Holder on any day on or
after the Issuance Date, in whole or in part by delivery of a written notice, in
the  form  attached hereto as Exhibit B (the "EXERCISE NOTICE"), of the Holder's
                              ---------
election  to  exercise  this  Warrant  and (ii) (A) payment to the Company of an
amount  equal  to  the  applicable  Exercise  Price  multiplied by the number of
Warrant  Shares  as  to  which  this  Warrant is being exercised (the "AGGREGATE
EXERCISE  PRICE") in cash or wire transfer of immediately available funds or (B)
by  notifying  the  Company  that  this Warrant is being exercised pursuant to a
Cashless  Exercise  (as  defined  in  Section  1(d)).  The  Holder  shall not be
required  to  deliver  the  original  Warrant  in  order  to  effect an exercise
hereunder.  Execution  and  delivery of the Exercise Notice with respect to less
than all of the Warrant Shares shall have the same effect as cancellation of the
original  Warrant and issuance of a new Warrant evidencing the right to purchase
the  remaining  number of Warrant Shares.  On or before the first (1st) Business
Day  following  the  date on which the Company has received each of the Exercise
Notice  and the Aggregate Exercise Price (or notice of a Cashless Exercise) (the
"EXERCISE  DELIVERY  DOCUMENTS"),  the  Company  shall  transmit by facsimile an
acknowledgment  of confirmation of receipt of the Exercise Delivery Documents to
the  Holder  and  the  Company's  transfer  agent (the "TRANSFER AGENT").  On or
before  the third (3rd) Business Day following the date on which the Company has
received all of the Exercise Delivery Documents (the "SHARE DELIVERY DATE"), the
Company  shall  (X)  provided  that  the  Transfer Agent is participating in The
Depository  Trust  Company  ("DTC")  Fast Automated Securities Transfer Program,
upon the request of the Holder, credit such aggregate number of shares of Common
Stock  to which the Holder is entitled pursuant to such exercise to the Holder's
or  its designee's balance account with DTC through its Deposit Withdrawal Agent
Commission  system, or (Y) if the Transfer Agent is not participating in the DTC
Fast  Automated  Securities  Transfer  Program,  issue and dispatch by overnight
courier  to  the  address  as  specified  in the Exercise Notice, a certificate,
registered  in  the  Company's  share  register in the name of the Holder or its
designee,  for  the  number  of  shares  of  Common Stock to which the Holder is
entitled  pursuant to such exercise.  If this Warrant is submitted in connection
with any exercise pursuant to this Section 1(a) and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of
Warrant  Shares  being acquired upon an exercise, then the Company shall as soon
as practicable and in no event later than three Business Days after any exercise
and  at  its  own expense, issue a new Warrant (in accordance with Section 7(d))
representing  the  right  to  purchase  the number of Warrant Shares purchasable
immediately  prior  to  such  exercise  under  this  Warrant, less the number of
Warrant  Shares  with respect to which this Warrant is exercised.  No fractional
shares  of  Common Stock are to be issued upon the exercise of this Warrant, but
rather  the number of shares of Common Stock to be issued shall be rounded up to
the  nearest whole number.  The Company shall pay any and all taxes which may be
payable  with  respect  to  the  issuance  and  delivery  of Warrant Shares upon
exercise  of  this  Warrant.

               (b)     Exercise  Price.  For purposes of this Warrant, "EXERCISE
                       ---------------
PRICE"  means  $1.62,  subject  to  adjustment  as  provided  herein.

               (c)     Company's  Failure  to Timely Deliver Securities.  If the
                       ------------------------------------------------
Company shall fail for any reason or for no reason to issue to the Holder within
three  (3)  Trading  Days  of  receipt  of  the  Exercise  Delivery Documents, a
certificate  for  the  number  of  shares  of  Common  Stock  to  which  the

                                        2
<PAGE>
Holder  is  entitled  and  register such shares of Common Stock on the Company's
share  register  or  to  credit  the  Holder's balance account with DTC for such
number  of  shares  of  Common  Stock  to  which the Holder is entitled upon the
Holder's  exercise  of  this  Warrant,  then,  in addition to all other remedies
available to the Holder, the Company shall pay in cash to the Holder on each day
after such third Trading Day that the issuance of such shares of Common Stock is
not timely effected an amount equal to 0.5% of the product of (A) the sum of the
number  of shares of Common Stock not issued to the Holder on a timely basis and
to  which the Holder is entitled and (B) the Closing Sale Price of the shares of
Common  Stock  on  the  Trading Day immediately preceding the last possible date
which  the  Company  could have issued such shares of Common Stock to the Holder
without  violating  Section 1(a).  In addition to the foregoing, if within three
(3) Trading Days after the Company's receipt of the facsimile copy of a Exercise
Notice  the  Company shall fail to issue and deliver a certificate to the Holder
and  register  such  shares  of  Common Stock on the Company's share register or
credit  the Holder's balance account with DTC for the number of shares of Common
Stock  to  which the Holder is entitled upon such holder's exercise hereunder or
if  the  Company  fails to deliver to the Holder the certificate or certificates
representing  the  applicable  Warrant  Shares  (or  credit the Holder's balance
account at DTC with the applicable Warrant Shares) within three (3) Trading Days
after  its  obligation  to do so under clause (ii) below and if on or after such
Trading  Day  the  Holder purchases (in an open market transaction or otherwise)
shares  of  Common  Stock  to deliver in satisfaction of a sale by the Holder of
shares  of  Common Stock issuable upon such exercise that the Holder anticipated
receiving  from  the  Company (a "BUY-IN"), then the Company shall, within three
Trading  Days  after the Holder's request and in the Holder's discretion, either
(i)  pay  cash  to  the Holder in an amount equal to the Holder's total purchase
price  (including  brokerage commissions, if any) for the shares of Common Stock
so  purchased  (the  "BUY-IN PRICE"), at which point the Company's obligation to
deliver  such  certificate  (and to issue such shares of Common Stock) or credit
such  Holder's  balance account with DTC shall terminate, or (ii) promptly honor
its  obligation  to  deliver  to  the  Holder  a  certificate  or  certificates
representing such shares of Common Stock or credit such Holder's balance account
with DTC and pay cash to the Holder in an amount equal to the excess (if any) of
the  Buy-In Price over the product of (A) such number of shares of Common Stock,
times (B) the proceeds per share received by such Holder as a result of the sale
to  which  the  Buy-In  relates.

               (d)     Cashless  Exercise.  Notwithstanding  anything  contained
                       ------------------
herein  to  the  contrary,  if  a  Registration  Statement  (as  defined  in the
Securities  Purchase Agreement) covering the Warrant Shares that are the subject
of  the  Exercise Notice (the "UNAVAILABLE WARRANT SHARES") is not available for
the  resale  of  such  Unavailable  Warrant  Shares, the Holder may, in its sole
discretion, exercise this Warrant in whole or in part and, in lieu of making the
cash payment otherwise contemplated to be made to the Company upon such exercise
in  payment  of the Aggregate Exercise Price, elect instead to receive upon such
exercise  the "Net Number" of shares of Common Stock determined according to the
following  formula  (a  "CASHLESS  EXERCISE"):

               Net  Number  =  (A  x  B)  -  (A  x  C)
                               -----------------------

                                          B

                                        3
<PAGE>
               For  purposes  of  the  foregoing  formula:

          A=  the  total  number of shares with respect to which this Warrant is
then  being  exercised.

          B=  the  Weighted  Average  Price  of  the  shares of Common Stock (as
reported  by Bloomberg)  for the five (5) consecutive Trading Days ending on the
date  immediately  preceding  the  date  of  the  Exercise  Notice.

          C= the Exercise Price then in effect for the applicable Warrant Shares
at  the  time  of  such  exercise.

               (e)     Disputes.  In  the  case  of  a  dispute  as  to  the
                       --------
determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares,  the  Company  shall  promptly issue to the Holder the number of Warrant
Shares that are not disputed and resolve such dispute in accordance with Section
12.

               (f)     Limitations  on  Exercises.  The Company shall not effect
                       --------------------------
the  exercise  of  this  Warrant,  and  the  Holder  shall not have the right to
exercise  this Warrant, to the extent that after giving effect to such exercise,
such  Person  (together with such Person's affiliates) would beneficially own in
excess  of  4.99%  (the  "MAXIMUM  PERCENTAGE")  of  the  shares of Common Stock
outstanding  immediately  after giving effect to such exercise.  For purposes of
the  foregoing  sentence,  the  aggregate  number  of  shares  of  Common  Stock
beneficially owned by such Person and its affiliates shall include the number of
shares  of  Common  Stock issuable upon exercise of this Warrant with respect to
which the determination of such sentence is being made, but shall exclude shares
of  Common  Stock  which  would  be issuable upon (i) exercise of the remaining,
unexercised  portion  of  this Warrant beneficially owned by such Person and its
affiliates  and  (ii)  exercise  or conversion of the unexercised or unconverted
portion of any other securities of the Company beneficially owned by such Person
and  its  affiliates  (including,  without  limitation, any convertible notes or
convertible  preferred  stock or warrants) subject to a limitation on conversion
or  exercise  analogous to the limitation contained herein.  Except as set forth
in  the preceding sentence, for purposes of this paragraph, beneficial ownership
shall  be calculated in accordance with Section 13(d) of the Securities Exchange
Act  of 1934, as amended (the "EXCHANGE ACT").  For purposes of this Warrant, in
determining  the  number  of  outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in (1) the
Company's  most  recent  Form 10-K, Form 10-KSB, Form 10-Q, Form 10-QSB, Current
Report  on  Form  8-K  or  other  public filing with the Securities and Exchange
Commission,  as  the  case  may be, (2) a more recent public announcement by the
Company  or  (3)  any  other notice by the Company or the Transfer Agent setting
forth  the  number of shares of Common Stock outstanding.  For any reason at any
time,  upon  the written or oral request of the Holder, the Company shall within
one Trading Day confirm orally and in writing to the Holder the number of shares
of Common Stock then outstanding.  In any case, the number of outstanding shares
of  Common  Stock  shall  be determined after giving effect to the conversion or
exercise of securities of the Company, including the SPA Warrants, by the Holder
and  its affiliates since the date as of which such number of outstanding shares
of  Common Stock was reported.  By written notice to the Company, the Holder may
increase  or  decrease  the  Maximum  Percentage  to any other percentage not in
excess  of  9.99%  specified in such notice; provided that (i) any such increase
will  not  be  effective  until  the  sixty-first  (61st)  day

                                        4
<PAGE>
after  such  notice  is  delivered to the Company, and (ii) any such increase or
decrease  will  apply  only  to  the  Holder  and not to any other holder of SPA
Warrants.

               (g)     Insufficient  Authorized  Shares.  If  at  any time while
                       --------------------------------
this  Warrant  remains outstanding the Company does not have a sufficient number
of authorized and unreserved shares of Common Stock to satisfy its obligation to
reserve  for  issuance upon exercise of this Warrant at least a number of shares
of  Common  Stock equal to 100% (the "REQUIRED RESERVE AMOUNT") of the number of
shares  of  Common  Stock  as shall from time to time be necessary to effect the
exercise  of  all  of  this  Warrant  then  outstanding  (an  "AUTHORIZED  SHARE
FAILURE"),  then  the  Company  shall  immediately  take all action necessary to
increase the Company's authorized shares of Common Stock to an amount sufficient
to  allow  the  Company  to reserve the Required Reserve Amount for this Warrant
then outstanding.  Without limiting the generality of the foregoing sentence, as
soon  as  practicable  after  the  date of the occurrence of an Authorized Share
Failure,  but in no event later than one hundred and twenty (120) days after the
occurrence of such Authorized Share Failure, the Company shall hold a meeting of
its  stockholders  for  the  approval of an increase in the number of authorized
shares  of  Common  Stock.  In  connection  with such meeting, the Company shall
provide  each  stockholder  with  a proxy statement and shall use its reasonable
best  efforts  to  solicit  its  stockholders'  approval  of  such  increase  in
authorized  shares  of  Common  Stock  and  to  cause  its board of directors to
recommend  to  the  stockholders  that  they  approve  such  proposal.

                                        5
<PAGE>
          2.     ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES.   If
                 ---------------------------------------------------------
the  Company  at  any  time on or after the Subscription Date subdivides (by any
stock  split, stock dividend, recapitalization or otherwise) one or more classes
of  its  outstanding shares of Common Stock into a greater number of shares, the
Exercise  Price  in  effect  immediately  prior  to  such  subdivision  will  be
proportionately reduced and the number of Warrant Shares will be proportionately
increased.  If  the  Company  at  any  time  on  or  after the Subscription Date
combines  (by combination, reverse stock split or otherwise) one or more classes
of  its  outstanding shares of Common Stock into a smaller number of shares, the
Exercise  Price  in  effect  immediately  prior  to  such  combination  will  be
proportionately  increased  and  the  number  of  Warrant  Shares  will  be
proportionately  decreased.  Any  adjustment  under  this Section 2 shall become
effective  at  the  close of business on the date the subdivision or combination
becomes  effective.

          3.     RIGHTS  UPON DISTRIBUTION OF ASSETS.  In case the Company shall
                 -----------------------------------
fix  a  payment  date  for the making of a distribution to all holders of Common
Stock  of evidences of indebtedness or assets (other than cash dividends or cash
distributions  payable  out  of  consolidated  earnings  or  earned  surplus  or
dividends  or  distributions referred to in Section 2), the Exercise Price to be
in  effect  after  such  payment  date  shall  be  determined by multiplying the
Exercise  Price  in effect immediately prior to such payment date by a fraction,
the  numerator  of  which  shall  be  the total number of shares of Common Stock
outstanding  multiplied  by the Weighted Average Price per share of Common Stock
immediately  prior  to  such  payment  date,  less  the  fair  market  value (as
determined  by the Company's Board of Directors in good faith) of said assets or
evidences  of indebtedness so distributed, and the denominator of which shall be
the  total  number  of  shares  of  Common  Stock outstanding multiplied by such
Weighted  Average  Price  per  share  of  Common Stock immediately prior to such
payment  date.  Such  adjustment  shall  be  made  successively  whenever such a
payment  date  is  fixed.

          4.     PURCHASE  RIGHTS;  FUNDAMENTAL  TRANSACTIONS.
                 --------------------------------------------

               (a)     Purchase Rights.  In addition to any adjustments pursuant
                       ---------------
to  Section  2  above,  if  at  any time the Company grants, issues or sells any
Options,  Convertible  Securities  or  rights  to  purchase  stock,  warrants,
securities  or  other  property  pro  rata to the record holders of any class of
shares of Common Stock (the "PURCHASE RIGHTS"), then the Holder will be entitled
to  acquire,  upon  the  terms applicable to such Purchase Rights, the aggregate
Purchase  Rights which the Holder could have acquired if the Holder had held the
number  of  shares  of  Common  Stock  acquirable upon complete exercise of this
Warrant  (without  regard  to  any  limitations on the exercise of this Warrant)
immediately  before  the date on which a record is taken for the grant, issuance
or  sale of such Purchase Rights, or, if no such record is taken, the date as of
which  the record holders of shares of Common Stock are to be determined for the
grant,  issue  or  sale  of  such  Purchase  Rights.

               (b)     Fundamental  Transactions.  The  Company  shall not enter
                       -------------------------
into  or  be party to a Fundamental Transaction unless (i)  the Successor Entity
assumes  in writing all of the obligations of the Company under this Warrant and
the  other  Transaction  Documents  in  accordance  with  the provisions of this
Section  (4)(b)  prior  to such Fundamental Transaction, including agreements to
deliver  to  each holder of Warrants in exchange for such Warrants a security of
the  Successor Entity evidenced by a written instrument substantially similar in
form  and  substance to this Warrant, including, without limitation, an adjusted
exercise  price  equal  to  the

                                        6
<PAGE>
value  for the shares of Common Stock reflected by the terms of such Fundamental
Transaction,  and  exercisable  for  a corresponding number of shares of capital
stock  equivalent  to  the shares of Common Stock acquirable and receivable upon
exercise  of  this Warrant (without regard to any limitations on the exercise of
this  Warrant)  prior to such Fundamental Transaction and (ii) (I) the Successor
Entity  (or  its  Parent  Entity)  is a publicly traded corporation whose common
stock  is  quoted  on  or  listed  for trading on an Eligible Market or (II) the
Successor  Entity  is  a  private  company  and  the  consideration paid in such
Fundamental  Transaction  is  solely cash consideration.  Upon the occurrence of
any  Fundamental  Transaction,  the  Successor  Entity  shall succeed to, and be
substituted  for  (so  that  from  and  after  the  date  of  such  Fundamental
Transaction,  the  provisions  of  this Warrant referring to the "Company" shall
refer  instead  to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this
Warrant  with  the same effect as if such Successor Entity had been named as the
Company herein.  Upon consummation of the Fundamental Transaction, the Successor
Entity  shall deliver to the Holder confirmation that there shall be issued upon
exercise  of  this Warrant at any time after the consummation of the Fundamental
Transaction,  in  lieu  of  the shares of the Common Stock (or other securities,
cash,  assets  or  other  property  purchasable upon the exercise of the Warrant
prior  to  such Fundamental Transaction, such shares of stock, securities, cash,
assets or any other property whatsoever (including warrants or other purchase or
subscription  rights)  which the Holder would have been entitled to receive upon
the  happening  of  such Fundamental Transaction had this Warrant been converted
immediately  prior  to  such  Fundamental Transaction, as adjusted in accordance
with the provisions of this Warrant.  In addition to and not in substitution for
any  other  rights  hereunder,  prior  to  the  consummation  of any Fundamental
Transaction  pursuant to which holders of shares of Common Stock are entitled to
receive  securities or other assets with respect to or in exchange for shares of
Common Stock (a "CORPORATE EVENT"), the Company shall make appropriate provision
to  insure  that  the  Holder  will thereafter have the right to receive upon an
exercise  of  this Warrant within ninety (90) days after the consummation of the
Fundamental  Transaction but prior to the Expiration Date, in lieu of the shares
of  the  Common  Stock  (or  other  securities,  cash, assets or other property)
purchasable  upon  the  exercise  of  the  Warrant  prior  to  such  Fundamental
Transaction,  such  shares  of  stock,  securities,  cash,  assets  or any other
property  whatsoever  (including  warrants  or  other  purchase  or subscription
rights)  which the Holder would have been entitled to receive upon the happening
of such Fundamental Transaction had the Warrant been exercised immediately prior
to  such  Fundamental  Transaction.  The  provisions of this Section shall apply
similarly  and  equally  to  successive  Fundamental  Transactions and Corporate
Events and shall be applied without regard to any limitations on the exercise of
this  Warrant.

          5.     NONCIRCUMVENTION.  The Company hereby covenants and agrees that
                 ----------------
the  Company  will not, by amendment of its Certificate of Incorporation, Bylaws
or through any reorganization, transfer of assets, consolidation, merger, scheme
of arrangement, dissolution, issue or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms
of  this  Warrant,  and  will  at  all  times  in  good  faith carry out all the
provisions of this Warrant and take all action as may be required to protect the
rights  of  the  Holder.  Without  limiting the generality of the foregoing, the
Company  (i)  shall  not  increase  the  par value of any shares of Common Stock
receivable  upon  the  exercise of this Warrant above the Exercise Price then in
effect  and, (ii) shall take all such actions as may be necessary or appropriate
in  order  that  the  Company  may  validly  and  legally  issue  fully paid and
nonassessable  shares  of  Common  Stock  upon  the  exercise  of  this Warrant.

                                        7
<PAGE>
          6.     WARRANT  HOLDER  NOT DEEMED A STOCKHOLDER.  Except as otherwise
                 -----------------------------------------
specifically  provided herein, the Holder, solely in such Person's capacity as a
holder of this Warrant, shall not be entitled to vote or receive dividends or be
deemed  the  holder  of  share capital of the Company for any purpose, nor shall
anything  contained  in  this  Warrant  be  construed to confer upon the Holder,
solely  in  such  Person's  capacity  as  the Holder of this Warrant, any of the
rights  of  a  stockholder of the Company or any right to vote, give or withhold
consent  to  any  corporate  action (whether any reorganization, issue of stock,
reclassification  of  stock,  consolidation,  merger,  conveyance or otherwise),
receive  notice  of  meetings,  receive  dividends  or  subscription  rights, or
otherwise,  prior to the issuance to the Holder of the Warrant Shares which such
Person  is  then  entitled to receive upon the due exercise of this Warrant.  In
addition,  nothing  contained in this Warrant shall be construed as imposing any
liabilities  on  the  Holder  to  purchase any securities (upon exercise of this
Warrant  or  otherwise)  or  as  a  stockholder  of  the  Company,  whether such
liabilities  are  asserted  by  the  Company  or  by  creditors  of the Company.
Notwithstanding this Section 6, the Company shall provide the Holder with copies
of  the  same  notices  and  other  information given to the stockholders of the
Company  generally,  contemporaneously  with  the  giving  thereof  to  the
stockholders.

          7.     REISSUANCE  OF  WARRANTS.
                 ------------------------

               (a)     Transfer  of  Warrant.  If  this  Warrant  is  to  be
                       ---------------------
transferred,  the  Holder shall surrender this Warrant to the Company, whereupon
the  Company will forthwith issue and deliver upon the order of the Holder a new
Warrant (in accordance with Section 7(d)), registered as the Holder may request,
representing  the  right  to  purchase  the  number  of  Warrant  Shares  being
transferred  by  the Holder and, if less then the total number of Warrant Shares
then  underlying this Warrant is being transferred, a new Warrant (in accordance
with  Section  7(d)) to the Holder representing the right to purchase the number
of  Warrant  Shares  not  being  transferred.

               (b)     Lost,  Stolen  or Mutilated Warrant.  Upon receipt by the
                       -----------------------------------
Company  of  evidence reasonably satisfactory to the Company of the loss, theft,
destruction  or  mutilation  of this Warrant, and, in the case of loss, theft or
destruction,  of any indemnification undertaking by the Holder to the Company in
customary  form  and, in the case of mutilation, upon surrender and cancellation
of  this  Warrant,  the  Company  shall  execute and deliver to the Holder a new
Warrant (in accordance with Section 7(d)) representing the right to purchase the
Warrant  Shares  then  underlying  this  Warrant.

               (c)     Exchangeable  for  Multiple  Warrants.  This  Warrant  is
                       -------------------------------------
exchangeable, upon the surrender hereof by the Holder at the principal office of
the  Company,  for  a  new Warrant or Warrants (in accordance with Section 7(d))
representing in the aggregate the right to purchase the number of Warrant Shares
then underlying this Warrant, and each such new Warrant will represent the right
to  purchase  such portion of such Warrant Shares as is designated by the Holder
at  the  time  of  such  surrender;  provided,  however,  that  no  Warrants for
fractional  shares  of  Common  Stock  shall  be  given.

               (d)     Issuance  of  New  Warrants.  Whenever  the  Company  is
                       ---------------------------
required  to issue a new Warrant pursuant to the terms of this Warrant, such new
Warrant  (i)  shall be of like tenor with this Warrant, (ii) shall represent, as
indicated  on  the  face  of such new Warrant, the right to purchase the Warrant
Shares  then  underlying  this  Warrant  (or  in the case of a new Warrant being
issued

                                        8
<PAGE>
pursuant  to  Section 7(a) or Section 7(c), the Warrant Shares designated by the
Holder  which, when added to the number of shares of Common Stock underlying the
other  new Warrants issued in connection with such issuance, does not exceed the
number  of  Warrant  Shares  then  underlying this Warrant), (iii) shall have an
issuance date, as indicated on the face of such new Warrant which is the same as
the  Issuance  Date,  and (iv) shall have the same rights and conditions as this
Warrant.

          8.     NOTICES.  Whenever  notice  is  required to be given under this
                 -------
Warrant,  unless  otherwise  provided  herein,  such  notice  shall  be given in
accordance  with  Section  9  of the Securities Purchase Agreement.  The Company
shall  provide  the  Holder  with  prompt  written  notice  of all actions taken
pursuant  to  this Warrant, including in reasonable detail a description of such
action  and  the  reason  therefore.  Without  limiting  the  generality  of the
foregoing,  the  Company  will give written notice to the Holder (i) immediately
upon  any  adjustment of the Exercise Price, setting forth in reasonable detail,
and  certifying,  the  calculation of such adjustment and (ii) at least ten (10)
days  prior  to the date on which the Company closes its books or takes a record
(A) with respect to any dividend or distribution upon the shares of Common Stock
or  (B)  with  respect  to  any  grants,  issuances  or  sales  of  any Options,
Convertible  Securities  or  rights  to  purchase stock, warrants, securities or
other  property  to  holders  of  shares  of  Common  Stock.

          9.     AMENDMENT AND WAIVER.  Except as otherwise provided herein, the
                 --------------------
provisions  of  this  Warrant may be amended and the Company may take any action
herein prohibited, or omit to perform any act herein required to be performed by
it,  only  if  the  Company  has  obtained  the  written consent of the Required
Holders; provided that no such action may increase the exercise price of any SPA
Warrant  or  decrease  the  number  of  shares or class of stock obtainable upon
exercise  of any SPA Warrant without the written consent of the Holder.  No such
amendment  shall  be effective to the extent that it applies to less than all of
the  holders  of  the  SPA  Warrants  then  outstanding.

          10.     GOVERNING  LAW  AND  FORUM.  This Warrant shall be governed by
                  --------------------------
and construed and enforced in accor-dance with, and all questions concerning the
construction,  validity, interpretation and performance of this Warrant shall be
governed  by,  the  internal  laws of the State of New York.  The parties hereto
agree to submit to the exclusive jurisdiction of the federal and state courts of
the  State of New York with respect to the interpretation of this Warrant or for
the  purposes  of  any  action  arising  out  of  or  related  to  this Warrant.

          11.     CONSTRUCTION;  HEADINGS.  This  Warrant  shall be deemed to be
                  -----------------------
jointly drafted by the Company and all the Purchasers and shall not be construed
against  any person as the drafter hereof.  The headings of this Warrant are for
convenience  of  reference  and  shall  not  form  part  of,  or  affect  the
interpretation  of,  this  Warrant.

          12.     DISPUTE  RESOLUTION.  In  the  case  of  a  dispute  as to the
                  -------------------
determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares,  the  Company  shall  submit  the  disputed determinations or arithmetic
calculations  via  facsimile  within  two  (2)  Business  Days of receipt of the
Exercise  Notice giving rise to such dispute, as the case may be, to the Holder.
If  the  Holder  and  the Company are unable to agree upon such determination or
calculation  of  the  Exercise Price or the Warrant Shares within three Business
Days of such disputed determination or arithmetic calculation being submitted to
the  Holder,  then  the  Company  shall, within two (2) Business Days submit via
facsimile  the  disputed  determination  of  the

                                        9
<PAGE>
Exercise  Price  to  an  independent,  reputable investment bank selected by the
Company  and approved by the Holder.  The Company shall cause at its expense the
investment  bank  to  perform  the determinations or calculations and notify the
Company  and the Holder of the results no later than ten (10) Business Days from
the  time  it  receives  the  disputed  determinations  or  calculations.  Such
investment  bank's or accountant's determination or calculation, as the case may
be,  shall  be  binding  upon  all  parties  absent  demonstrable  error.

          13.     REMEDIES,  OTHER  OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF.
                  -------------------------------------------------------------
The remedies provided in this Warrant shall be cumulative and in addition to all
other remedies available under this Warrant and the other Transaction Documents,
at  law  or  in  equity (including a decree of specific performance and/or other
injunctive  relief),  and  nothing herein shall limit the right of the Holder to
pursue actual damages for any failure by the Company to comply with the terms of
this  Warrant.  The  Company acknowledges that a breach by it of its obligations
hereunder  will  cause irreparable harm to the Holder and that the remedy at law
for  any  such  breach may be inadequate.  The Company therefore agrees that, in
the  event  of  any such breach or threatened breach, the holder of this Warrant
shall be entitled, in addition to all other available remedies, to an injunction
restraining  any  breach,  without  the  necessity  of showing economic loss and
without  any  bond  or  other  security  being  required.

          14.     TRANSFER.     This  Warrant  may  be  offered  for sale, sold,
                  --------
transferred  or  assigned  without  the  consent  of  the Company, except as may
otherwise be required by Section 6.3 of the Securities Purchase Agreement.  This
Warrant  is  a  "restricted  security"  as  such  term  is  defined  in Rule 144
promulgated  under  the  Securities  Act  and  must  be held indefinitely unless
transferred  pursuant  to  an exemption from registration or qualification under
applicable  state  and  federal  securities  laws.

          15.     CERTAIN  DEFINITIONS.  For  purposes  of  this  Warrant,  the
                  --------------------
following  terms  shall  have  the  following  meanings:

               (a)     "BLOOMBERG"  means  Bloomberg  Financial  Markets.

               (b)     "BUSINESS  DAY" means any day other than Saturday, Sunday
or other day on which commercial banks in The City of New York are authorized or
required  by  law  to  remain  closed.

               (c)     "CLOSING  BID  PRICE" and "CLOSING SALE PRICE" means, for
any  security  as of any date, the last closing bid price and last closing trade
price,  respectively,  for such security on the Principal Market, as reported by
Bloomberg,  or,  if  the Principal Market begins to operate on an extended hours
basis  and  does not designate the closing bid price or the closing trade price,
as  the  case  may  be,  then  the  last  bid  price  or  the  last trade price,
respectively, of such security prior to 4:00 p.m., New York Time, as reported by
Bloomberg,  or, if the Principal Market is not the principal securities exchange
or  trading  market  for such security, the last closing bid price or last trade
price,  respectively,  of  such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg,
or  if  the  foregoing  do  not  apply, the last closing bid price or last trade
price,  respectively,  of  such  security  in the over-the-counter market on the
electronic  bulletin board for such security as reported by Bloomberg, or, if no
closing  bid  price  or  last  trade  price,  respectively, is reported for such
security  by  Bloomberg,  the  average  of  the  bid

                                       10
<PAGE>
prices,  or the ask prices, respectively, of any market makers for such security
as  reported  in  the  "pink  sheets"  by Pink Sheets LLC (formerly the National
Quotation  Bureau,  Inc.).  If  the  Closing Bid Price or the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing
bases,  the  Closing Bid Price or the Closing Sale Price, as the case may be, of
such security on such date shall be the fair market value as mutually determined
by  the  Company  and  the  Holder.  If the Company and the Holder are unable to
agree  upon  the  fair market value of such security, then such dispute shall be
resolved  pursuant  to  Section 12.  All such determinations to be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar
transaction  during  the  applicable  calculation  period.

               (d)     "COMMON  STOCK"  means (i) the Company's shares of Common
Stock,  $0.01 par value, and (ii) any share capital into which such Common Stock
shall  have  been changed or any share capital resulting from a reclassification
of  such  Common  Stock.

               (e)     "CONVERTIBLE  SECURITIES"  means  any stock or securities
(other  than  Options) directly or indirectly convertible into or exercisable or
exchangeable  for  shares  of  Common  Stock.

               (f)     "ELIGIBLE  MARKET"  means  the  Principal  Market,  the
American  Stock  Exchange, The New York Stock Exchange, Inc., The NASDAQ Capital
Market  or  The  NASDAQ  Global  Select  Market.

               (g)     "EXPIRATION  DATE" means the date sixty (60) months after
the  Issuance Date or, if such date falls on a day other than a Trading Day, the
next  Trading  Day.

               (h)     "FUNDAMENTAL  TRANSACTION"  means that the Company shall,
directly  or indirectly, in one or more related transactions, (i) consolidate or
merge  with  or  into  (whether or not the Company is the surviving corporation)
another  Person,  or (ii) sell, assign, transfer, convey or otherwise dispose of
all  or  substantially all of the properties or assets of the Company to another
Person,  or  (iii)  allow  another Person to make a purchase, tender or exchange
offer  that  is  accepted  by  the  holders  of  more than the 50% of either the
outstanding  shares  of  Common  Stock (not including any shares of Common Stock
held  by  the  Person or Persons making or party to, or associated or affiliated
with  the  Persons making or party to, such purchase, tender or exchange offer),
or  (iv)  consummate  a  stock  purchase agreement or other business combination
(including,  without limitation, a reorganization, recapitalization or scheme of
arrangement)  with  another  Person whereby such other Person acquires more than
the  50%  of the outstanding shares of Common Stock (not including any shares of
Common  Stock  held  by the other Person or other Persons making or party to, or
associated  or  affiliated with the other Persons making or party to, such stock
purchase  agreement  or  other  business  combination),  or  (v)  reorganize,
recapitalize or reclassify its Common Stock, or (vi) any "person" or "group" (as
these  terms  are  used for purposes of Sections 13(d) and 14(d) of the Exchange
Act)  is  or shall become the "beneficial owner" (as defined in Rule 13d-3 under
the  Exchange  Act),  directly  or  indirectly, of 50% of the aggregate ordinary
voting  power  represented  by  issued  and  outstanding  Common  Stock.

               (i)     "OPTIONS"  means  any  rights,  warrants  or  options  to
subscribe  for  or  purchase  shares  of Common Stock or Convertible Securities.

                                       11
<PAGE>
               (j)     "PARENT  ENTITY"  of  a  Person  means  an  entity  that,
directly or indirectly, controls the applicable Person and whose common stock or
equivalent  equity  security  is  quoted or listed on an Eligible Market, or, if
there is more than one such Person or Parent Entity, the Person or Parent Entity
with  the largest public market capitalization as of the date of consummation of
the  Fundamental  Transaction.

               (k)     "PERSON"  means  an  individual,  a  limited  liability
company,  a  partnership,  a  joint  venture,  a  corporation,  a  trust,  an
unincorporated organization, any other entity and a government or any department
or  agency  thereof.

               (l)     "PRINCIPAL  MARKET"  means  The  NASDAQ  Global  Market.

               (m)     "REQUIRED  HOLDERS" means the holders of the SPA Warrants
representing  at  least  a majority of shares of Common Stock underlying the SPA
Warrants  then  outstanding.

               (n)     "SUCCESSOR ENTITY" means the Person (or, if so elected by
the  Required Holders, the Parent Entity) formed by, resulting from or surviving
any  Fundamental  Transaction  or  the  Person  with  which  such  Fundamental
Transaction  shall  have  been  entered  into.

               (o)     "TRADING  DAY" means any day on which the Common Stock is
traded on the Principal Market, or, if the Principal Market is not the principal
trading  market  for the Common Stock, then on the principal securities exchange
or  securities  market  on  which the Common Stock is then traded; provided that
"Trading  Day"  shall not include any day on which the Common Stock is scheduled
to  trade on such exchange or market for less than 4.5 hours or any day that the
Common  Stock is suspended from trading during the final hour of trading on such
exchange  or market (or if such exchange or market does not designate in advance
the  closing  time  of  trading on such exchange or market, then during the hour
ending  at  4:00  p.m.,  New  York  Time).

               (p)     "WEIGHTED  AVERAGE  PRICE"  means, for any security as of
any  date,  the  dollar  volume-weighted  average price for such security on the
Principal  Market  during the period beginning at 9:30 a.m., New York City time,
and  ending  at  4:00 p.m., New York City time, as reported by Bloomberg through
its  "Volume  at Price" function or, if the foregoing does not apply, the dollar
volume-weighted average price of such security in the over-the-counter market on
the  electronic  bulletin board for such security during the period beginning at
9:30  a.m.,  New York City time, and ending at 4:00 p.m., New York City time, as
reported  by  Bloomberg,  or,  if  no  dollar  volume-weighted  average price is
reported  for  such  security  by  Bloomberg  for such hours, the average of the
highest  closing bid price and the lowest closing ask price of any of the market
makers  for  such  security  as reported in the "pink sheets" by Pink Sheets LLC
(formerly  the  National Quotation Bureau, Inc.).  If the Weighted Average Price
cannot  be  calculated  for  such  security on such date on any of the foregoing
bases,  the  Weighted  Average  Price of such security on such date shall be the
fair  market  value  as  mutually  determined  by  the  Company and the Required
Holders.  If  the  Company and the Required Holders are unable to agree upon the
fair  market  value  of  the  such security, then such dispute shall be resolved
pursuant  to Section 12 with the term "Weighted Average Price" being substituted
for  the  term  "Exercise Price." All such determinations shall be appropriately
adjusted for any share dividend, share split or other similar transaction during
such  period.

                            [SIGNATURE PAGE FOLLOWS]

                                       12
<PAGE>
     IN  WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common
Stock  to  be  duly  executed  as  of  the  Issuance  Date  set  out  above.

                                        CONCURRENT  COMPUTER  CORPORATION

                                        By:
                                             -----------------------------------
                                                 Name:
                                                 Title:

<PAGE>
EXHIBIT  A

                                 EXERCISE NOTICE
            TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS
                        WARRANT TO PURCHASE COMMON STOCK

                         CONCURRENT COMPUTER CORPORATION
     The  undersigned  holder  hereby  exercises  the  right  to  purchase
                  of the shares of Common Stock ("WARRANT SHARES") of Concurrent
-----------------
Computer  Corporation,  a Delaware corporation (the "COMPANY"), evidenced by the
attached  Warrant  to  Purchase Common Stock (the "WARRANT").  Capitalized terms
used  herein  and  not  otherwise defined shall have the respective meanings set
forth  in  the  Warrant.

     1.  Form  of  Exercise  Price.  The  Holder  intends  that  payment  of the
Exercise  Price  shall  be  made  as:

                           a  "Cash  Exercise" with respect to
          ------------        ----------------                 -----------------
                    Warrant  Shares;  and/or

                           a "Cashless Exercise" with respect to
          ------------       -------------------                 ---------------
                    Warrant  Shares.

     2.  Payment  of Exercise Price.  In the event that the holder has elected a
Cash  Exercise  with  respect  to some or all of the Warrant Shares to be issued
pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of
$                    to the Company in accordance with the terms of the Warrant.
 -------------------

     3.  Delivery  of  Warrant  Shares.  The Company shall deliver to the holder
            Warrant  Shares  in  accordance  with  the  terms  of  the  Warrant.
----------

Date:                     ,
       ---------------  --   ------

-----------------------------------
   Name  of  Registered  Holder

By:
     ------------------------------
         Name:
         Title:

<PAGE>
                                 ACKNOWLEDGMENT

     The  Company  hereby  acknowledges  this Exercise Notice and hereby directs
American  Stock  Transfer & Trust Company to issue the above indicated number of
shares  of Common Stock in accordance with the Transfer Agent Instructions dated
May  18,  2007 from the Company and acknowledged and agreed to by American Stock
Transfer  &  Trust  Company.

                                        CONCURRENT COMPUTER CORPORATION

                                        By:
                                             -----------------------------------
                                             Name:
                                             Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]